Trial intelligence / Profile preview

Diode Laser vs Ciclopirox for Onychomycosis

NCT05809297Phase 4Unknown

Sponsor
Complutense University of Madrid
Start
Sep 2023
Primary completion
Apr 2024
01

Overview

Phase 4, randomised, open-label trial (2 arms), sponsored by Complutense University of Madrid. Primary endpoint: Efficacy of treatment of onychomycosis at 12 months. Status: unknown.

Beyond the preview

Go deeper on NCT05809297.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05809297.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call